Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
about
Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptidesInfective endocarditis; report from a main referral teaching hospital in Iran.Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infectionsSurveillance and epidemiology of MRSA bacteraemia in the UK.Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adultsGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the EuTigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.Intravenous device associated blood stream staphylococcal infection in paediatric patientsBloodstream Bacterial Pathogens and their Antibiotic Resistance Pattern in Dhahira Region, Oman.In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococciSingle-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistance.Antibacterial susceptibility patterns and cross-resistance of acinetobacter, isolated from hospitalized patients, southern iran.Ertapenem: review of a new carbapenem.Global challenge of multidrug-resistant Acinetobacter baumanniiMRSA--what is it, and how do we deal with the problem?Tigecycline: a new glycylcycline for treatment of serious infections.A guide to antibiotic resistance in bacterial skin infections.Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA).Novel approaches to developing new antibiotics for bacterial infections.Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.Empiric therapy for febrile neutropenia: what are the choices?Incidence of Pseudomonas aeruginosa bacteremia: a population-based studyTrends in paediatric and adult bloodstream infections at a Ghanaian referral hospital: a retrospective study.Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance.2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the EurEpidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.Structural Elucidation and Molecular Docking of a Novel Antibiotic Compound from Cyanobacterium Nostoc sp. MGL001.Antimicrobial activity of tigecycline and comparative agents against clinical isolates of staphylococci and enterococci from ICUs and general hospital wards at three Swedish university hospitals.Epidemiological Profile of Linezolid‐Resistant Coagulase‐Negative Staphylococci
P2860
Q26861137-6A09661D-A458-4433-BC8F-A6764694C207Q33652266-0FBFBD31-C137-4BBC-8785-2EEC8424A767Q34352287-DC52BF92-3FD9-4C5F-A36F-7E81A29679ACQ34437381-2E61F3EC-D766-43B6-882B-35F0664AC362Q34510697-A3A16294-6452-43FF-8E70-07B59A8A22ECQ34611253-7DABD457-AE74-42C5-96A8-539CE07F5BDDQ34803735-E06C23A9-5870-4BEC-B5BA-E36452F2BDD8Q35234581-E408FA1C-0D3D-4C5A-9779-A24034C00AC4Q35324504-EC275532-1DB6-4CA1-A690-3EF7ADB035F9Q35647735-744ACC42-167B-48A5-8BB8-648599260A91Q35759063-0BC84DFF-25D8-4233-8348-0DD8F1A16F82Q35976330-8AD80903-4946-4C17-8FDE-C1A78AAE2BCEQ36022229-4FE7F112-B7C4-4C6F-8869-DA8A58D5B9DFQ36066200-D7B9D9BD-641E-48FC-9F28-07F93486B7B2Q36095081-3553DF0D-5919-486F-9586-D470FC4C0973Q36150828-C9A3A12E-84A7-4C6A-82DA-C5A023B3B1DDQ36218312-260C0539-5061-4779-8915-4AED167E9AD6Q36258130-FADBEB6D-3532-4C07-A5FD-8F5BAB7C7A0DQ36315377-977ED9B4-292A-4DED-BE96-C918DAB473CBQ36358643-44411074-DD5A-4B25-99C0-4EA354993333Q36719706-7D9BA753-D9FB-46BF-847B-B8AE7C407814Q36839750-9387A680-EF7D-4410-9FCE-91D060E6C86FQ37041262-8160ADE6-9728-4BB9-AB77-2D2325074389Q37189214-D2F376AA-F4AA-4ECB-812C-08128963E410Q38009935-AEA890F0-3968-4E5F-AC50-1973BBB8C017Q41026009-89B6A50F-C8DA-4F9F-9B88-2427D187EC76Q41195981-CE839D78-D4AE-4945-900E-285E6AABF2FEQ41757382-884EED2C-579A-42A0-8343-2EB5806450BCQ42362560-E6D4615D-2E75-41BC-8C64-674E0FD7BC80Q46144628-DB6B7A25-5384-40DE-9764-26B22498D3CFQ59230736-5F138382-3718-46EB-B37C-C087AA972855
P2860
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antimicrobial susceptibility o ...... stance Surveillance Programme.
@en
type
label
Antimicrobial susceptibility o ...... stance Surveillance Programme.
@en
prefLabel
Antimicrobial susceptibility o ...... stance Surveillance Programme.
@en
P2093
P356
P1476
Antimicrobial susceptibility o ...... stance Surveillance Programme.
@en
P2093
Alasdair MacGowan
Andrea Williams
BSAC Extended Working Party on Bacteraemia Resistance Surveillance
David Livermore
Melissa Colman
Nicola Potz
Rosy Reynolds
P304
P356
10.1093/JAC/DKH232
P407
P577
2004-05-05T00:00:00Z